ImaginAb
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
423 Hindry Ave Ste D, Inglewood, Califor...Phone Number
(310) 645-1211Website
www.imaginab.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About ImaginAb
ImaginAb is an immune and oncology imaging company developing a pipeline of novel products that give physicians unprecedented insights into the patients healthenabling better patient selection and treatment monitoring for immuno-oncology therapies and other drugs. Established in 2007, ImaginAb is headquartered in California, United States.Explore more
ImaginAb Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ImaginAb your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if ImaginAb has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if ImaginAb is spiking on competitors!
Click to see if ImaginAb had a recent Job posting/layoffs
Earning: See what the market has to say on ImaginAb recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at ImaginAb
Product Launch: Get notified when ImaginAb launches new products
Funding: Get notified immidiatlly once ImaginAb has new funding data
ImaginAb, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined ImaginAb as Masked Content
Find 2 more new buyers
Compare Similar Companies to ImaginAb
Compare insights from companies similar to ImaginAb, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ImaginAb is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ImaginAb is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ImaginAb.
ImaginAb financials insights
Gather financial insights about ImaginAb, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Series A
$12.5M
2014
Series B
$21M
2016
Private Equity
$5.3M
2017
Private Equity
$7.7M
2020
Debt
$150K
2021
Other Financing Round
$12.8M
ImaginAb Tech Stack
A closer look at the technologies used by ImaginAb
Most Recent Scoops
Event
Product Marketing, Events, Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology
Event
Product Marketing, Events, Software, Field /Outside Sales, Field Marketing, Healthcare Operations, Healthcare Technology
Event
Product Marketing, Events, Research & Development, Bioengineering, Medical Research, Clinical Operations, Healthcare Technology
Event
Events
Open Position
ImaginAb News & Media
ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery
INGLEWOOD, Calif., Jan. 22, 2025 /PRNewswire/ -- ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, proprietary novel biologics technology platform, and a protein engineering and discovery research facility to...ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery
INGLEWOOD, Calif., Jan. 22, 2025 /PRNewswire/ -- ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, proprietary novel biologics technology platform, and a protein engineering and discovery research facility to...Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb, Inc. (ImaginAb) to acquire a pipeline of next-generation therapeutic candidates, proprietary novel biologics technology platform, and a protein engineering and discovery research facility to enhance existing innovation capabilities.ImaginAb Advances Two Solid Tumor Radiopharmaceutical Therapy (RPT) Candidates Towards Clinical Development
IAB56 RPT agent is designed to target integrin αvβ6, a receptor over-expressed in a broad range of solid cancers underserved by current cancer therapies. IAB57 RPT agent is designed to target DLL3, a target over-expressed in cancer tissues and relevant in several cancers, most notably...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding ImaginAb
Sign Up For FreeTo access detailed company insights
ImaginAb is an immune and oncology imaging company developing a pipeline of novel products that give physicians unprecedented insights into the patients healthenabling better patient selection and treatment monitoring for immuno-oncology therapies and other drugs. Established in 2007, ImaginAb is headquartered in California, United States.... Read More
